跳至主要内容
临床试验/NCT01130870
NCT01130870已完成不适用

Dose Response Curve - Sacral Nerve Stimulation for Faecal Incontinence

University of Aarhus1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2010年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
1
主要终点
Number of incontinence episodes Assess number of incontinence episodes.

研究概览

简要总结

The purpose of this study is to determine if subsensory stimulation (amplitude) will maintain same continence in patients treated with Sacral Nerve Stimulation (SNS) for faecal incontinence as stimulation with amplitude at sensory threshold.

详细描述

Faecal incontinence is a devastating condition with huge impact on quality of life. Sacral Nerve Stimulation (SNS) has since 1995 been a treatment option for patients not obtaining satisfactory continence result with standard non-surgical treatments. SNS is electrical stimulation of the sacral nerve root(s2,3 or 4). Stimulation of this nerve roots results in improved continence. The mechanism of action is at present not well described.

Standard the neuromodulator (pacemaker) stimulate with Frequency 14 Hz, pulse width 210 mic.sec. and amplitude set at sensory threshold. One study by SM. Koch et all confirms that subsensory stimulation can be effective. At present there is no doubled blinded study's to confirm this theory of effective sub sensory stimulation.

The aim of this study is to determine if subsensory stimulation will be as effective as stimulation with amplitude at sensory threshold. This will be investigated in 20 patients who have had at least a reduction in incontinence episodes or Wexner inc. score of 75 % between preimplantation and latest follow up. The patients will be randomized to three different amplitudes. 1: amplitude set at sensory threshold. 2: 75% of sensory threshold. 3: 50% of sensory threshold. The order of the three settings will be random and in a double blinded manner. The interval between these three pacemaker settings is four weeks. Patients serve as there own controls. Stimulation frequency (14 Hz) and pulse width (210 mic-sec) will remain fixed.

Evaluation will be by means of 4 week bowel habit diary and questionnaires (Wexner inc. score / St. Marks Score / Wexner constipation score / Altomares OD-score / IBS-score/ Rockwood FIQoL -score). All patients will be evaluated with anorectal measurements (sphincter strength and anorectal volume measurements) before any changes of stimulation amplitude.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18 years or older
  • •Informed consent
  • •Idiopathic fecal incontinence or Fecal incontinence due to small sphincter defect(≤60 o)
  • •fecal incontinence after primary/secondary sphincter repair
  • •Permanent neuromodulator (medtronic InterStim / Interstim II) implanted for at least 12 weeks before entering the study.
  • •Reduction in fecal incontinence episodes of at least 75% between baseline and latest follow up.(Bowel diary card) or 75% reduction of Wexner Inc. score.
  • •Willing and competent to fill out diary cards

排除标准

  • •Colorectal/proctological surgery since IPG-implant
  • •Pregnancy
  • •Anorectal Pain

研究组 & 干预措施

Sensory threshold - Amplitude

Active Comparator

Stimulation amplitude set at sensory threshold.

干预措施: Sensory Threshold (Device)

25% below sensory threshold - Amplitude

Experimental

Stimulation amplitude 75% of sensory threshold.

干预措施: 75% of sensory threshold - Amplitude (Device)

50% below sensory threshold - Amplitude

Experimental

Stimulation with amplitude set 50% below sensory threshold

干预措施: 50% of sensory threshold - Amplitude (Device)

结局指标

主要结局

Number of incontinence episodes Assess number of incontinence episodes.

时间窗: Will be assessed every four weeks during a twelve-week period

Assess number of incontinence episodes, by means of bowel habit diary. Four week bowel habit diary will be evaluated three times during the twelve-week protocol perioed.

次要结局

  • Assess changes in anorectal volume and pressure with different amplitude.(Will be assessed every four weeks during a twelve-week period)
  • Assess Quality of life after decrease in stimulation amplitude.(Will be assessed every four weeks during a twelve-week period)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验